by Daniel X. Thomas
The patent relates to prodrugs of phosphonate nucleotide analogues and methods for selecting and making same.
Brief outline of the case
The patent results from a divisional application of EP01961695 / EP 1 301 519.
The OD decided maintenance according to AR 6.
All three opponents appealed this decision.
by Daniel X. Thomas
The patent relates to humanized antibodies that recognize human IL-23p19 and modulate its activity, particularly in inflammatory, autoimmune and proliferative disorders.
The case is interesting as it deals with the exercise of discretion by the OD when not- admitting late filed submissions of the opponent.
Brief outline of the procedure
The patent was revoked for lack of sufficiency by the OD.